Antitumor Activity of Fascaplysin Derivatives on Glioblastoma Model In Vitro


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Antitumor efficiency of fascaplysin synthetic derivatives (7-phenylfascaplysin, 3-chlorofascaplysin, 3-bromofascaplysin, and 10-bromofascaplysin) was compared out in vitro on C6 glioma cells. The cytotoxic efficiency of all tested compounds was higher than that of unsubstituted fascaplysin; 3-bromofascaplysin and 7-phenylfascaplysin exhibited the best capacity to kill glioma C6 cells. Apoptosis was the main mechanism of glioma cell death. The cytotoxic activity of these compounds increased with prolongation of exposure to the substance and increase of its concentration. Fascaplysin derivatives modified all phases of glioma cell vital cycle. The count of viable tumor cell in G0 phase remained minimum by the end of experiment under the effects of 3-bromofascaplysin and 7-phenylfascaplysin.

Sobre autores

I. Lyakhova

Biomedicine School, Far-Eastern Federal University

Autor responsável pela correspondência
Email: liakhova.ia@dvfu.ru
Rússia, Vladivostok

I. Bryukhovetsky

Biomedicine School, Far-Eastern Federal University; A. V. Zhirmunsky Institute of Marine Biology, Far-Eastern Division of the Russian Academy of Sciences

Email: liakhova.ia@dvfu.ru
Rússia, Vladivostok; Vladivostok

I. Kudryavtsev

Biomedicine School, Far-Eastern Federal University

Email: liakhova.ia@dvfu.ru
Rússia, Vladivostok

Yu. Khotimchenko

Biomedicine School, Far-Eastern Federal University; A. V. Zhirmunsky Institute of Marine Biology, Far-Eastern Division of the Russian Academy of Sciences

Email: liakhova.ia@dvfu.ru
Rússia, Vladivostok; Vladivostok

M. Zhidkov

Biomedicine School, Far-Eastern Federal University

Email: liakhova.ia@dvfu.ru
Rússia, Vladivostok

A. Kantemirov

Biomedicine School, Far-Eastern Federal University

Email: liakhova.ia@dvfu.ru
Rússia, Vladivostok


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies